Paradigm Biopharmaceuticals Limited (PAR.AX)
AUD 0.37
(-2.67%)
AUD 0.37
(-2.67%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -64.53 Million AUD | -9.27% |
| 2023 | -59.06 Million AUD | -26.15% |
| 2022 | -46.81 Million AUD | -11.12% |
| 2021 | -42.13 Million AUD | -151.59% |
| 2020 | -15.69 Million AUD | -40.31% |
| 2019 | -8.95 Million AUD | -33.94% |
| 2018 | -6.22 Million AUD | -45.9% |
| 2017 | -4.28 Million AUD | -41.51% |
| 2016 | -3.02 Million AUD | -58974.1% |
| 2015 | 7331.00 AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -49.82 Million AUD | 0.0% |
| 2024 Q4 | -14.89 Million AUD | 0.0% |
| 2024 FY | - AUD | -8.95% |
| 2023 Q4 | -26.84 Million AUD | 0.0% |
| 2023 Q2 | -32.21 Million AUD | 0.0% |
| 2023 FY | - AUD | -26.15% |
| 2022 Q4 | -19.65 Million AUD | 0.0% |
| 2022 FY | - AUD | -11.12% |
| 2022 Q2 | -27.15 Million AUD | 0.0% |
| 2021 FY | - AUD | -151.59% |
| 2021 Q4 | -21.39 Million AUD | 0.0% |
| 2021 Q2 | -20.74 Million AUD | 0.0% |
| 2020 Q4 | -11.86 Million AUD | 0.0% |
| 2020 Q2 | -5.01 Million AUD | 0.0% |
| 2020 FY | - AUD | -40.31% |
| 2019 Q2 | -4.39 Million AUD | 0.0% |
| 2019 FY | - AUD | -33.94% |
| 2019 Q4 | -4.55 Million AUD | 0.0% |
| 2018 Q2 | -3.56 Million AUD | 0.0% |
| 2018 Q4 | -2.66 Million AUD | 0.0% |
| 2018 FY | - AUD | -45.9% |
| 2017 Q2 | -2.81 Million AUD | 0.0% |
| 2017 FY | - AUD | -41.51% |
| 2017 Q4 | -1.46 Million AUD | 0.0% |
| 2016 Q4 | -1.6 Million AUD | 0.0% |
| 2016 FY | - AUD | -58974.1% |
| 2016 Q2 | -1.42 Million AUD | 0.0% |
| 2015 Q3 | - AUD | -100.0% |
| 2015 Q4 | 2380.00 AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q2 | 4951.00 AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 722.036% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -4330.617% |
| Zelira Therapeutics Limited | -36.44 Million AUD | -77.105% |
| Biome Australia Limited | -1.57 Million AUD | -3989.286% |
| Patrys Limited | -3.49 Million AUD | -1748.121% |
| Orthocell Limited | -11.68 Million AUD | -452.509% |
| Imugene Limited | -147.97 Million AUD | 56.386% |
| Noxopharm Limited | -5.94 Million AUD | -985.515% |
| PYC Therapeutics Limited | -38.11 Million AUD | -69.316% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | -471.154% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -798.161% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | -718.265% |
| Cynata Therapeutics Limited | -9.95 Million AUD | -548.622% |
| CSL Limited | 4.73 Billion AUD | 101.364% |
| Arovella Therapeutics Limited | -8.83 Million AUD | -630.647% |
| Bio-Gene Technology Limited | -2.97 Million AUD | -2069.394% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 224.442% |
| Starpharma Holdings Limited | -12.57 Million AUD | -413.153% |
| Nanollose Limited | -1.14 Million AUD | -5522.366% |
| Memphasys Limited | -3.3 Million AUD | -1851.168% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -8858.291% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | -3492.926% |
| Amplia Therapeutics Limited | -4.55 Million AUD | -1315.458% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | -363.665% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | -2190.153% |
| Race Oncology Limited | -14.2 Million AUD | -354.393% |
| Nyrada Inc. | -4.59 Million AUD | -1304.185% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 381.021% |
| Dimerix Limited | -24.95 Million AUD | -158.586% |
| PharmAust Limited | -9.45 Million AUD | -582.83% |
| Immutep Limited | -42.87 Million AUD | -50.528% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | -44.552% |
| Alterity Therapeutics Limited | -19.57 Million AUD | -229.759% |
| BTC Health Limited | 1.05 Million AUD | 6215.796% |
| Acrux Limited | -7.93 Million AUD | -713.759% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 132.389% |
| Biotron Limited | -5.04 Million AUD | -1180.526% |
| Tissue Repair Ltd | -5.77 Million AUD | -1017.563% |
| AdAlta Limited | -5.3 Million AUD | -1117.1% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | -42.232% |
| Hexima Limited | -995.54 Thousand AUD | -6382.814% |
| AnteoTech Limited | -11.57 Million AUD | -457.768% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | -202.233% |
| Avecho Biotechnology Limited | -3.24 Million AUD | -1890.409% |
| Actinogen Medical Limited | -12.92 Million AUD | -399.484% |
| Immuron Limited | -6.19 Million AUD | -942.24% |
| Argenica Therapeutics Limited | -1.89 Million AUD | -3301.112% |